JAC-AMR: BSAC Members to receive a 50% discount on standard article processing charge (APC)

20th July 2020

JAC-AMR is our fully open-access journal dedicated to exploring all aspects of antimicrobial resistance. For a limited time only, BSAC Members will recieve 50% discount on the standard article processing charge (APC).

Grants available from the International Society of Antimicrobial Chemotherapy

14th July 2020

The International Society of Antimicrobial Chemotherapy (ISAC) is offering small project grants (£5000 - £10,000) to applicants from ISAC member societies.

Immediate call for partner university and principal investigator for the further development of a UK Antimicrobial Registry (UKAR).

29th June 2020

BSAC is establishing a UK Drug Registry (UKAR) to provide prescribers and organisations the opportunity to capture real world usage of antimicrobial agents and identify where real clinical unmet needs lie. This will provide an invaluable resource for future research studies and also enable the sharing of best practice.

BSAC delighted to publish in relaunched APUA newsletter

18th June 2020

BSAC is delighted to be part of the Alliance for the Prudent Use of Antibiotics, now part of the International Society for Antimicrobial Chemotherapy.

BSAC calls for Minister to tackle superbugs and pandemics in response to inquiry on COVID-19 impact

17th June 2020

BSAC has made three key recommendations in its response to the UK Parliament’s Health and Social Care Select Committee’s inquiry, “Delivering Core NHS and Care Services during the Pandemic and Beyond”

BSAC responds to UN consultation on panel to coordinate action against superbugs

16th June 2020

Following the Interagency Coordination Group’s (IACG) recommendation that the UN Secretary General should establish an Independent Panel on Evidence on Action Against Antimicrobial Resistance, an advisory group was established to develop draft Terms of Reference (ToR) for the Panel. Here is the British Society for Antimicrobial Chemotherapy’s (BSAC) response to that draft.

BSAC calls for further life-saving support after $1million invested in its COVID-19 R&D fund

2nd June 2020

The British Society for Antimicrobial Chemotherapy (BSAC) has urged other companies and major donors to boost coronavirus (COVID-19) research and development after pharmaceutical company Pfizer awarded $1million to its grants programme.

Focusing on a brighter future: How an ultra-low-cost 3D printed microscope could revolutionise healthcare in LMICs

2nd June 2020

Access to quality-assured laboratory diagnosis has long been a challenge in low-income and middle-income countries (LMICs) resulting in delayed or inaccurate diagnosis and ineffective treatment. But innovative approaches to design are helping to reduce the cost and availability of life-saving equipment...

GP? Pharmacist? Researcher? Social Scientist? Whatever field you work in, if you’re committed to fighting infection then we want you to join us as a BSAC Member.
Become a member
I have read and agree to the Privacy Policy

Having trouble finding what you're after?